Search results

• Outsourcing of clinical trials to China
  

  Cinical trials market is finding outsourcing to China as an attractive offer because of it's cost-effectiveness and ease of finding ...

• ISO 13485:2003 in Brief
  

  While going through some reading material on Quality and Regulatory Affairs, I got a chance to read about ISO ...

• Birth of Google Health
  

  Recently IT Business Edge brought an interesting article about 'Birth of Google Health".  As it is obvious it talks about ...

• What is Quality?
  

  What is quality and why it is an important measure for an organization’s performance? In my opinion quality is ...

• New FDA Territory
  

  REMS or Risk Evaluation & Mitigation Strategies are the focus area of the Drug Legislative reforms of 2007 and has ...

• Rocky Entrepreneurial path to travel
  

  Recently I got several opportunities to attend networking meetings for start-up entrepreneurs in Palo Alto and thought that my ...

• Quick drug approval by the FDA creates uproar
  

  Several pharma companies have succeeded in getting their unsafe drugs approved by the Food and Drug Administration at ...

• Avastin Vs. Lucentis
  

   

  Bevacizumab or Avastin is a humanized

• Drop in inflation rates stirs biotech companies
  

  It has not been a good start for the capital markets due to drop in inflation rates. The ...

• Government labs to test chemicals on non-animal models
  

  The National Institutes of Health and the Environmental Protection Agency have decided to work along with the National ...

• Low key status of upcoming drugs
  

  A large number of pharmaceutical industries such as Pfizer Inc., GlaxoSmithKline Plc and Sanofi-Aventis SA are trying to ...

• Eschenbach on FDA and more….
  

  A scientific panel issued a report last year after assessing the FDA’s fitness to protect the safety of the ...

• FDA to appoint staff overseas
  

  The FDA has decided to appoint staff overseas to perform ...

• Clinical Trial Outsourcing
  

  Pharmaceutical industry has been experiencing a turbulent ride in ...

• Biotech Sectors ready to develop personalized drugs
  

  Many of the biotechnology companies are very keen to create personalized medicine tests and therapies ...